%0 Journal Article
%T Leiomyosarcoma with partial rhabdomyoblastic differentiation: First case report of primary cardiac origin
%A Yoichiro Okubo
%A Kazutoshi Shibuya
%A Atsushi Namiki
%A Kazuhisa Takamura
%A Noriaki Kameda
%A Tetsuo Nemoto
%A Aki Mitsuda
%A Megumi Wakayama
%A Minoru Shinozaki
%A Nobuyuki Hiruta
%A Kanako Kitahara
%A Takao Ishiwatari
%A Junichi Yamazaki
%J BMC Cancer
%D 2011
%I BioMed Central
%R 10.1186/1471-2407-11-76
%X A 69-year-old woman was referred to our hospital for an operation concerning umbilical hernia. Subsequent imaging examinations before an operation indicated the presence of primary cardiac malignant tumor due to its atypical shape. And then, it was surgically removed. Histopathologically, tumor cells consisted of two different types: spindle and polyhedral cells. Immunohistochemically, it is interesting to note that 2.1% of spindle cells and 23.1% of polyhedral cells showed positive reactivity for myogenin. Furthermore, we performed double-immunostaining for alpha-smooth muscle actin (SMA) and myogenin. The rates of alpha-SMA and myogenin double negative, alpha-SMA single positive, myogenin single positive, and alpha-SMA and myogenin double positive in spindle cells were estimated as 69.1%, 28.8%, 1.1% and 1.0%, respectively. In contrast, the rates in polyhedral cells were estimated as 76.9%, 0.0%, 23.1%, and 0.0%, respectively.Our immunohistochemical evaluation suggested that rhabdomyoblastic differentiation in leiomyosarcoma might be generated not only by de novo generation from mesenchymal cells. To the best of our knowledge, this is the first case of primary cardiac leiomyosarcoma with partial rhabdomyoblastic differentiation.Primary cardiac tumors represent a rare neoplastic condition with an incidence that ranges from 0.0017 to 0.019% [1], of which 25% are malignant. Among such tumors, angiosarcoma is the commonest malignant tumor followed by rhabdomyosarcoma, malignant mesothelioma, and fibrosarcoma, each with an incidence that is greater than 10% [2]. However, the incidence of cardiac leiomyosarcoma is less than 1% [2]. Previous studies of leiomyosarcoma with rhabdomyoblastic differentiation have conducted to those arisen from another site [3-11], and they announced a poorer prognosis of this tumor. Especially, Oshiro et al. have reported that leiomyosarcoma with rhabdomyoblastic differentiation shows poorer prognosis than typical leiomyosarcoma [6]. In the
%U http://www.biomedcentral.com/1471-2407/11/76